TRADING UPDATES: Warehouse REIT buys Bradwell Abbey; Ixico wins deal
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read moreWed, 10th Mar 2021 14:30
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Sharecast News) - Artificial intelligence (AI) neuroimaging company Ixico announced on Thursday that it has been selected by a new client to support a global prospective observational study, assessing participants for the early detection of Huntington's disease (HD).
Read more(Sharecast News) - Medical analysis company Ixico has been selected by an existing United States biotechnology client, it announced on Tuesday, to provide PET and MRI neuroimaging services for an open-label phase 1 and 2 dose-finding study.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - Shares in Ixico PLC on Monday rose after the company announced the launch of its new brain segmentation platform IXIQ Ai.
Read more(Sharecast News) - Medical imaging analytics company Ixico has been selected to provide PET and MRI imaging services to an unnamed "leading European biopharmaceutical company" specialising in neurodegenerative conditions, it announced on Tuesday.
Read moreAIM WINNERS & LOSERS: Joules up on upbeat outlook; Numis quarter slow
Read moreIxico wins GBP1 million contract to provide medical imaging services
Read more(Sharecast News) - Data analytics company Ixico has extended its commitment to Dementias Platform UK (DPUK), it announced on Wednesday, as it entered its second phase.
Read moreIN BRIEF: IXICO will see 2022 revenue drop after contract canceled
Read moreAIM WINNERS & LOSERS: Parity and Brave Bison expect to beat forecasts
Read moreUK shareholder meetings calendar - next 7 days
Read moreIxico sees "significant growth" despite notable headwinds; shares up
Read moreUK earnings, trading statements calendar - next 7 days
Read more(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been selected by its largest pharmaceutical client to provide neuroimaging services for a new phase 3 clinical trial focussed on a demyelinating disorder, it announced on Monday.
Read more